136 related articles for article (PubMed ID: 10726258)
21. Empty sella syndrome associated with a hyperfunctioning microadenoma invading the clivus.
Coulson CJ; Siddiq MA; Johnson AP
Br J Neurosurg; 2007 Dec; 21(6):623-5. PubMed ID: 18071980
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; Reubi JC; Lamberts SW
Ann N Y Acad Sci; 1994 Sep; 733():416-24. PubMed ID: 7978890
[No Abstract] [Full Text] [Related]
23. [Applications of somatostatin receptor scintigraphy in oncology: the need to incorporate SPECT into the imaging protocol].
Valdés Olmos RA
Rev Esp Med Nucl; 2003; 22(2):65-7. PubMed ID: 12646093
[No Abstract] [Full Text] [Related]
24. Somatostatin receptor tumor imaging (Tc 99m P829) in pituitary adenoma.
Chiewvit S; Chiewvit P; Pusuwan P; Sriussadaporn S; Ratanamart V
J Med Assoc Thai; 1999 Dec; 82(12):1208-13. PubMed ID: 10659562
[TBL] [Abstract][Full Text] [Related]
25. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy.
Chen CC; Czerwiec FS; Feuillan PP
J Nucl Med; 1998 Feb; 39(2):238-40. PubMed ID: 9476926
[TBL] [Abstract][Full Text] [Related]
26. What is a false-positive somatostatin receptor scintigraphy?
Reubi JC
J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
[No Abstract] [Full Text] [Related]
27. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of primary empty sella syndrome by computed tomography.
Ketonen L; Kuuliala I
Ann Clin Res; 1979 Aug; 11(4):125-8. PubMed ID: 517991
[TBL] [Abstract][Full Text] [Related]
30. CT iopamidol cisternographic diagnosis of coexisting partial empty sella and pituitary adenoma. Report of two cases.
Pompili A; Iachetti M; Bianchini AL; Crecco M; Giannini P; Mastrostefano R
Neuroradiology; 1987; 29(1):93-4. PubMed ID: 3155420
[TBL] [Abstract][Full Text] [Related]
31. Imaging technology in the diagnosis of sellar disease.
Pagán-Sáez H; Milán R
P R Health Sci J; 1994 Jun; 13(2):143-51. PubMed ID: 7938401
[TBL] [Abstract][Full Text] [Related]
32. Coexisting pituitary adenomas and partially empty sellas.
Domingue JN; Wing SD; Wilson CB
J Neurosurg; 1978 Jan; 48(1):23-8. PubMed ID: 619021
[TBL] [Abstract][Full Text] [Related]
33. The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.
Dörr U; Sautter-Bihl ML; Bihl H
Semin Oncol; 1994 Oct; 21(5 Suppl 13):42-5. PubMed ID: 7992080
[No Abstract] [Full Text] [Related]
34. [Ectopic pituitary adenoma associated with empty sella turcica].
Zelaya MV; Bacaicoa C; Zazpe I; Gomez Dorronsoro M
Rev Esp Patol; 2019; 52(4):256-259. PubMed ID: 31530410
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid adenoma visualization on octreotide scintigraphy.
Boulahdour H; Bertrand AM; Klingelschmitt S; Rudenko B; Loboguerrero A; Bidet AC; Mantion G; Cardot JC
Clin Nucl Med; 2002 Apr; 27(4):304-5. PubMed ID: 11914679
[No Abstract] [Full Text] [Related]
36. Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index.
Duet M; Mundler O; Ajzenberg C; Berolatti B; Chedin P; Duranteau L; Warnet A
Eur J Nucl Med; 1994 Jul; 21(7):647-50. PubMed ID: 7957351
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Colao A; Pivonello R; Lastoria S; Faggiano A; Ferone D; Lombardi G; Fenzi G
Eur J Endocrinol; 2000 Oct; 143 Suppl 1():S35-42. PubMed ID: 11068938
[No Abstract] [Full Text] [Related]
38. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
[TBL] [Abstract][Full Text] [Related]
39. Ectopic pituitary adenoma associated with an empty sella: a case report and review of the literature.
Kusano Y; Horiuchi T; Oya F; Miyaoka Y; Oguchi K; Takemae T; Hongo K
J Neuroimaging; 2013 Jan; 23(1):135-6. PubMed ID: 21699614
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin-receptor scintigraphy in Graves' orbitopathy.
Postema PT; Kwekkeboom DJ; van Hagen PM; Krenning EP
Eur J Nucl Med; 1996 Jun; 23(6):615-7. PubMed ID: 8662098
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
